{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:54:03Z","timestamp":1793040843795,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The dual-hit model of schizophrenic psychoses suggests that epigenetic alterations may contribute to the disease pathogenesis. Given the significant synaptic loss in patients with schizophrenia (SZ) during puberty, we investigated DNA-methylation patterns of key synaptic target molecules: dopamine transporter (DAT), dopamine receptor D2 (DRD2), microtubule-associated protein tau (MAPT), and postsynaptic density protein 95 (PSD95). Analyses were performed in both blood and cerebrospinal fluid (CSF) samples from patients with SZ (n\u2009=\u200936) and healthy controls (Co) (n\u2009=\u200923). Due to the minimal amount of cell-free DNA available in CSF, different extraction methods were evaluated to achieve the best possible recovery. Ultimately, an adapted ethanol-glycogen precipitation protocol combined with a subsequent bead-based fusion and DNA clean-up was applied. However, despite comparable DNA concentrations obtained from Co and SZ CSF samples, only very few sequences could be obtained from CSF samples of Co, so that results concerning CSF measurements are limited to patients with SZ. In DAT, methylation was significantly higher in the blood of Co compared to both the blood and CSF of patients with SZ. In PSD95, mean methylation levels were higher in the CSF than in the blood of patients with SZ, whereas no difference was detected in the blood between SZ and Co. For MAPT and DRD2, no significant differences in mean methylation rates were observed between groups. Low sequencing success in CSF from Co, despite comparable concentrations to SZ, might point to a higher degree of fragmentation. In SZ, longer DNA fragments may be replenished more frequently. Higher central methylation of PSD95 in patients with SZ, a key regulator of glutamatergic neurotransmission, may reduce gene transcription and thus support the glutamate hypothesis of SZ, which assumes impaired glutamate receptor function. Lower DAT methylation in SZ compared to Co (with similar central and peripheral levels) could indicate a higher availability of the transporter at the synapse in SZ, resulting in a higher clearance of dopamine. This could be a compensatory mechanism concerning the hypothesis of dopaminergic hyperactivity in SZ.<\/jats:p>","DOI":"10.1038\/s41537-026-00738-x","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:37:49Z","timestamp":1771580269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential DNA-methylation of synaptic genes in CSF and blood in schizophrenia"],"prefix":"10.1038","volume":"12","author":[{"given":"Kirsten","family":"Jahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4407-3557","authenticated-orcid":false,"given":"Adrian","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5574-6818","authenticated-orcid":false,"given":"Ole","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Moschny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Frieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Felix","family":"Konen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"738_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0022-3956(99)00039-4","volume":"33","author":"TA Bayer","year":"1999","unstructured":"Bayer, T. A., Falkai, P. & Maier, W. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the \u201ctwo hit hypothesis. J. Psychiatr. Res. 33, 543\u2013548 (1999).","journal-title":"J. Psychiatr. Res."},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/0022034509335868","volume":"88","author":"SP Barros","year":"2009","unstructured":"Barros, S. P. & Offenbacher, S. Epigenetics: connecting environment and genotype to phenotype and disease. J. Dent. Res 88, 400\u2013408 (2009).","journal-title":"J. Dent. Res"},{"key":"738_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/mp.2014.94","volume":"20","author":"KS Kendler","year":"2015","unstructured":"Kendler, K. S. A joint history of the nature of genetic variation and the nature of schizophrenia. Mol. Psychiatry 20, 77\u201383 (2015).","journal-title":"Mol. Psychiatry"},{"key":"738_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0959-437X(99)80024-0","volume":"9","author":"HH Ng","year":"1999","unstructured":"Ng, H. H. Bird A. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9, 158\u2013163 (1999).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"738_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","volume":"128","author":"AD Goldberg","year":"2007","unstructured":"Goldberg, A. D., Allis, C. D. & Bernstein, E. Epigenetics: a landscape takes shape. Cell 128, 635\u2013638 (2007).","journal-title":"Cell"},{"key":"738_CR6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","volume":"69","author":"E Li","year":"1992","unstructured":"Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915\u2013926 (1992).","journal-title":"Cell"},{"key":"738_CR7","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.5694\/j.1326-5377.2009.tb02368.x","volume":"190","author":"MR Bennett","year":"2009","unstructured":"Bennett, M. R. Synapse formation and regression in the cortex during adolescence and in schizophrenia. Med J. Aust. 190, S14\u2013S16 (2009).","journal-title":"Med J. Aust."},{"key":"738_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","volume":"128","author":"L Sakka","year":"2011","unstructured":"Sakka, L., Coll, G. & Chazal, J. Anatomy and physiology of cerebrospinal fluid. Eur. Ann. Otorhinolaryngol. Head. Neck Dis. 128, 309\u2013316 (2011).","journal-title":"Eur. Ann. Otorhinolaryngol. Head. Neck Dis."},{"key":"738_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1208\/s12248-021-00587-9","volume":"23","author":"A Sun","year":"2021","unstructured":"Sun, A. & Wang, J. Choroid plexus and drug removal mechanisms. AAPS J. 23, 61 (2021).","journal-title":"AAPS J."},{"key":"738_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-11-10","volume":"11","author":"T Brinker","year":"2014","unstructured":"Brinker, T., Stopa, E., Morrison, J. & Klinge, P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11, 10 (2014).","journal-title":"Fluids Barriers CNS"},{"key":"738_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0920-9964(01)00294-8","volume":"57","author":"JH Gilmore","year":"2002","unstructured":"Gilmore, J. H. & Bouldin, T. W. Analysis of ependymal abnormalities in subjects with schizophrenia, bipolar disorder, and depression. Schizophrenia Res. 57, 267\u2013271 (2002).","journal-title":"Schizophrenia Res."},{"key":"738_CR12","doi-asserted-by":"crossref","unstructured":"Wojtkowska, M. et al. Quantification of circulating cell-free DNA in idiopathic Parkinson\u2019s disease patients. Int. J. Mol. Sci. 25, 2818 (2024).","DOI":"10.3390\/ijms25052818"},{"key":"738_CR13","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.4103\/1673-5374.335794","volume":"17","author":"D Southwood","year":"2022","unstructured":"Southwood, D., Singh, S. & Chatterton, Z. Brain-derived cell-free DNA. Neural Regen. Res 17, 2213\u20132214 (2022).","journal-title":"Neural Regen. Res"},{"key":"738_CR14","doi-asserted-by":"publisher","first-page":"1114762","DOI":"10.3389\/fgene.2022.1114762","volume":"13","author":"A Tripathy","year":"2022","unstructured":"Tripathy, A. et al. Liquid biopsy in pediatric brain tumors. Front Genet 13, 1114762 (2022).","journal-title":"Front Genet"},{"key":"738_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41537-019-0074-z","volume":"5","author":"A Petty","year":"2019","unstructured":"Petty, A. et al. Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia. NPJ Schizophr. 5, 6 (2019).","journal-title":"NPJ Schizophr."},{"key":"738_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuron.2006.09.015","volume":"52","author":"CA Ross","year":"2006","unstructured":"Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M. & Coyle, J. T. Neurobiology of schizophrenia. Neuron 52, 139\u2013153 (2006","journal-title":"Neuron"},{"key":"738_CR17","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1038\/tp.2016.257","volume":"7","author":"TD Purves-Tyson","year":"2017","unstructured":"Purves-Tyson, T. D. et al. Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain. Transl. psychiatry 7, e1003 (2017).","journal-title":"Transl. psychiatry"},{"key":"738_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41398-022-02253-w","volume":"12","author":"AO Kruse","year":"2022","unstructured":"Kruse, A. O. & Bustillo, J. R. Glutamatergic dysfunction in Schizophrenia. Transl. Psychiatry 12, 500 (2022).","journal-title":"Transl. Psychiatry"},{"key":"738_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrn1118","volume":"4","author":"J Lerma","year":"2003","unstructured":"Lerma, J. Roles and rules of kainate receptors in synaptic transmission. Nat. Rev. Neurosci. 4, 481\u2013495 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"738_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/nyas.12547","volume":"1338","author":"W Hu","year":"2015","unstructured":"Hu, W., MacDonald, M. L., Elswick, D. E. & Sweet, R. A. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann. N. Y. Acad. Sci. 1338, 38\u201357 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"738_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pnpbp.2017.11.016","volume":"82","author":"AA Coley","year":"2018","unstructured":"Coley, A. A. & Gao, W. J. PSD95: a synaptic protein implicated in schizophrenia or autism? Prog. Neuropsychopharmacol. Biol. Psychiatry 82, 187\u2013194 (2018).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"738_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.mp.4001844","volume":"11","author":"LV Kristiansen","year":"2006","unstructured":"Kristiansen, L. V., Beneyto, M., Haroutunian, V. & Meador-Woodruff, J. H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 11, 737\u2013747 (2006).","journal-title":"Mol. Psychiatry"},{"key":"738_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000507670","volume":"80","author":"K Jahn","year":"2021","unstructured":"Jahn, K. et al. Differential methylation pattern of schizophrenia candidate genes in tetrahydrocannabinol-consuming treatment-resistant schizophrenic patients compared to non-consumer patients and healthy controls. Neuropsychobiology 80, 36\u201344 (2021).","journal-title":"Neuropsychobiology"},{"key":"738_CR24","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1007\/s12640-022-00592-6","volume":"40","author":"HA Ruiz-Contreras","year":"2022","unstructured":"Ruiz-Contreras, H. A. et al. Modulatory activity of the endocannabinoid system in the development and proliferation of cells in the CNS. Neurotox. Res 40, 1690\u20131706 (2022).","journal-title":"Neurotox. Res"},{"key":"738_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11126-017-9507-x","volume":"88","author":"OF Demirel","year":"2017","unstructured":"Demirel, O. F. et al. Total tau and phosphorylated tau protein serum levels in patients with schizophrenia compared with controls. Psychiatr. Q 88, 921\u2013928 (2017","journal-title":"Psychiatr. Q"},{"key":"738_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.schres.2005.02.015","volume":"76","author":"JJ Miguel-Hidalgo","year":"2005","unstructured":"Miguel-Hidalgo, J. J., Dubey, P., Shao, Q., Stockmeier, C. & Rajkowska, G. Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression. Schizophrenia Res. 76, 159\u2013171 (2005).","journal-title":"Schizophrenia Res."},{"key":"738_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1042\/BST20120045","volume":"40","author":"A Rovelet-Lecrux","year":"2012","unstructured":"Rovelet-Lecrux, A. & Campion, D. Copy number variations involving the microtubule-associated protein tau in human diseases. Biochem. Soc. Trans. 40, 672\u2013676 (2012).","journal-title":"Biochem. Soc. Trans."},{"key":"738_CR28","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.pnpbp.2006.04.007","volume":"30","author":"SI Deutsch","year":"2006","unstructured":"Deutsch, S. I., Rosse, R. B. & Lakshman, R. M. Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer\u2019s disease, frontotemporal dementia and schizophrenia with therapeutic implications. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 1369\u20131380 (2006).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"738_CR29","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/bioinformatics\/bth346","volume":"20","author":"J Lewin","year":"2004","unstructured":"Lewin, J., Schmitt, A. O., Adorjan, P., Hildmann, T. & Piepenbrock, C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20, 3005\u20133012 (2004).","journal-title":"Bioinformatics"},{"key":"738_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41380-024-02735-x","volume":"30","author":"D Marques","year":"2025","unstructured":"Marques, D., Vaziri, N., Greenway, S. C. & Bousman, C. DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review. Mol. Psychiatry 30, 296\u2013309 (2025).","journal-title":"Mol. Psychiatry"},{"key":"738_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.jcp.0000096247.29231.3a","volume":"23","author":"CA Rijcken","year":"2003","unstructured":"Rijcken, C. A., Monster, T. B., Brouwers, J. R. & de Jong-van den Berg, L. T. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? J. Clin. Psychopharmacol. 23, 657\u2013659 (2003).","journal-title":"J. Clin. Psychopharmacol."},{"key":"738_CR32","first-page":"282","volume":"26","author":"MBJ Schmau\u00df","year":"2019","unstructured":"Schmau\u00df, M. B. J. & M\u00fcller, W. E. Weiterbildungs-Curriculum psychopharmakologie\/pharmaktherapie. Psychopharmakotherapie 26, 282\u2013298 (2019).","journal-title":"Psychopharmakotherapie"},{"key":"738_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/clinchem\/hvad115","volume":"70","author":"AK Afflerbach","year":"2024","unstructured":"Afflerbach, A. K. et al. Classification of brain tumors by nanopore sequencing of cell-free DNA from cerebrospinal fluid. Clin. Chem. 70, 250\u2013260 (2024).","journal-title":"Clin. Chem."},{"key":"738_CR34","doi-asserted-by":"publisher","first-page":"fcaa235","DOI":"10.1093\/braincomms\/fcaa235","volume":"3","author":"Z Ye","year":"2021","unstructured":"Ye, Z. et al. Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain. Brain Commun. 3, fcaa235 (2021).","journal-title":"Brain Commun."},{"key":"738_CR35","doi-asserted-by":"publisher","first-page":"12564","DOI":"10.1038\/s41598-020-69432-x","volume":"10","author":"M Alcaide","year":"2020","unstructured":"Alcaide, M. et al. Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. Sci. Rep. 10, 12564 (2020).","journal-title":"Sci. Rep."},{"key":"738_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40291-025-00773-x","volume":"29","author":"N Swarup","year":"2025","unstructured":"Swarup, N. et al. Cell-free DNA: features and attributes shaping the next frontier in liquid biopsy. Mol. Diagn. Ther. 29, 277\u2013290 (2025).","journal-title":"Mol. Diagn. Ther."},{"key":"738_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/clinchem\/hvac086","volume":"68","author":"LYL Choy","year":"2022","unstructured":"Choy, L. Y. L. et al. Single-molecule sequencing enables long cell-free DNA detection and direct methylation analysis for cancer patients. Clin. Chem. 68, 1151\u20131163 (2022).","journal-title":"Clin. Chem."},{"key":"738_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.biopsych.2011.10.004","volume":"71","author":"Y Fan","year":"2012","unstructured":"Fan, Y., Abrahamsen, G., McGrath, J. J. & Mackay-Sim, A. Altered cell cycle dynamics in schizophrenia. Biol. psychiatry 71, 129\u2013135 (2012).","journal-title":"Biol. psychiatry"},{"key":"738_CR39","doi-asserted-by":"crossref","unstructured":"Lubotzky, A. et al. Elevated brain-derived cell-free DNA among patients with first psychotic episode - a proof-of-concept study. eLife 11, e76391 (2022).","DOI":"10.7554\/eLife.76391"},{"key":"738_CR40","unstructured":"Coulter B. SPRI Bead to Sample Ratio for DNA Cleanup and Size Selection. https:\/\/www.beckman.es\/reagents\/genomic\/cleanup-and-size-selection\/pcr\/bead-ratio2020."},{"key":"738_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jpsychires.2021.11.042","volume":"145","author":"K Jahn","year":"2022","unstructured":"Jahn, K. et al. Serotonin system-associated genetic and epigenetic changes in pedophilia and child sexual offending. J. Psychiatr. Res. 145, 60\u201369 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"738_CR42","doi-asserted-by":"crossref","unstructured":"Long M. D., Smiraglia D. J., Campbell M. J. The genomic impact of DNA CpG methylation on gene expression; relationships in prostate cancer. Biomolecules 7, 15 (2017).","DOI":"10.3390\/biom7010015"},{"key":"738_CR43","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/gb-2014-15-2-r37","volume":"15","author":"JR Wagner","year":"2014","unstructured":"Wagner, J. R. et al. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol. 15, R37 (2014).","journal-title":"Genome Biol."},{"key":"738_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484\u2013492 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"738_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","volume":"78","author":"DC Javitt","year":"2007","unstructured":"Javitt, D. C. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 78, 69\u2013108 (2007).","journal-title":"Int. Rev. Neurobiol."},{"key":"738_CR46","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/archgenpsychiatry.2009.80","volume":"66","author":"A Guilmatre","year":"2009","unstructured":"Guilmatre, A. et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 66, 947\u2013956 (2009).","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00738-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:02:06Z","timestamp":1773680526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1038\/s41537-026-00738-x","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}